Abstract
Perioperative cardiac complications are frequently associated with non-cardiac surgery, particularly with major vascular surgery. Because major vascular surgery is high-risk surgery, patients scheduled for aortic surgery, such as those affected by thoraco-abdominal aortic aneurysm, must be investigated to quantify the cardiac risk. Obviously, when surgery is urgent, surgical repair is the priority and the patient cannot be further investigated in order to evaluate a specific risk stratification, or adequately treated to improve the clinical conditions. When surgery is not urgent, a preoperative evaluation of the patient’s risk-factors is recommended. The risk stratification allows optimization of the perioperative management and identification and determination, when possible, of the strategy to reduce the cardiac risk and to improve the outcome. Among the several medical therapies proposed to reduce the cardiac risk in non-cardiac surgery, the use of beta-blockers and statins has been extensively studied and it is recommended in high-risk surgery patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009;30:2769–2812
Fleisher LA, Beckman JA, Brown KA et al. ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120:e169–e276
Maddox TM. Preoperative cardiovascular evaluation for noncardiac surgery. Mt Sinai J Med 2005; 72:185–192
Wirthlin DJ, Cambria RP. Surgery-specific considerations in the cardiac patient undergoing noncardiac surgery. Prog Cardiovasc Dis 1998;40:453–468
Devereaux PJ, Goldman L, Cook DJ et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005; 13:627–634
Landesberg G, Beattie WS, Mosseri M et al. Perioperative myocardial infarction. Circulation 2009; 119:2936–2944
Poldermans D, Hoeks SE, Feringa HH. Pre-operative risk assessment and risk reduction before surgery. J Am Coll Cardiol 2008;51:1913–1924
Schouten O, Dunkelgrun M, Feringa HH et al. Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2007;33:544–549
Goldman L, Caldera DL, Nussbaum SR et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845–850
Detsky AS, Abrams HB, Forbath N et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 1986; 146:2131–1214
Lee TH, Marcantonio ER, Mangione CM et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043–1049
Boersma E, Kertai MD, Schouten O et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 2005; 118:1134–1141
Biccard BM. Relationship between the inability to climb two flights of stairs and outcome after major non-cardiac surgery: implications for the pre-operative assessment of functional capacity. Anaesthesia 2005; 60:588–593
Wang TJ, Larson MG, Levy D et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655–663
Omland T, Sabatine MS, Jablonski KA et al. Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 2007;50:205–214
Ryding ADS, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery. A meta-analysis Anesthesiology 2009; 11:311–319
Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008;63:1226–1233
Cuthbertson BH, Amiri AR, Croal BL et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007;99:170–176
Etchells E, Meade M, Tomlinson G, Cook D. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis. J Vasc Surg 2002;36:534–540
Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003;89:1327–1334
Sicari R, Nihoyannopoulos P, Evangelista A et al. Stress Echocardiography Expert Consensus Statement — Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009;30:278–289
Das MK, Pellikka PA, Mahoney DW et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000;35:1647–1653
Guarracino F, Puttini M, Pirelli S et al. Il razionale d’uso del betabloccante nel perioperatorio del paziente sottoposto a chirurgia non cardiaca. G Ital Cardiol 2009; 10(11–12 Suppl 2):S3–S10
Juul AB, Wetterslev J, Gluud C et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006;332:1482
Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713–1720
Yang H, Raymer K, Butler R et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152:983–990
Lindenauer PK, Pekow P, Wang K et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349–361
Devereaux PJ, Yang H, Yusuf S et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839–1847
Schouten O, Boersma E, Hoeks S et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009;361:980–989
Schouten O, Kertai MD, Bax JJ et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 2005;95:658–660
Durazzo AE, Machado FS, Ikeoka DT et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004;39:967–975
Hindler K, Shaw AD, Samuels J et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105:1260–1272
Schouten O, Hoeks SE, Welten GM et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007; 100:316–320
Williams TM, Harken AH. Statins for surgical patients. Ann Surg 2008;247:30–37
McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795–2804
Howard-Alpe GM, de Bono J, Hudsmith L et al. Coronary artery stents and non-cardiac surgery. Br J Anaesth 2007;98:560–574
Poldermans D, Schouten O, Vidakovic R et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007;49:1763–1769
Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961–972
Nuttall GA, Brown MJ, Stombaugh JW et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109:588–595
Rabbitts JA, Nuttall GA, Brown MJ et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109:596–604
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Italia
About this chapter
Cite this chapter
Guarracino, F., Baldassarri, R. (2011). Preoperative Care of Patients with Thoraco-Abdominal Aortic Aneurysms. In: Chiesa, R., Melissano, G., Zangrillo, A. (eds) Thoraco-Abdominal Aorta. Springer, Milano. https://doi.org/10.1007/978-88-470-1857-0_15
Download citation
DOI: https://doi.org/10.1007/978-88-470-1857-0_15
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1856-3
Online ISBN: 978-88-470-1857-0
eBook Packages: MedicineMedicine (R0)